|
Opinion
Chasing
an elusive pot of gold
Market
Eyeing
global markets
India's biotechnology industry seems to be following the same
growth strategies of its Big Brother, the pharmaceutical sector.
Viveka Roychowdhury assesses the growth plans
Actis
Biologics to sell stake to PE firms
Actis Biologics (ABPL), the Indian arm of US Actis Biologics,
is planning to raise about $ 30 million by selling stake to
Private Equity (PE) players to build two new plants and market
a new process that will help other drug makers cut cost.
Guwahati
to get first NE biotech park
Tarun Gogoi, Chief Minister, Assam has directed the Department
of Science and Technology of the State to work out the modalities
for a biotech park in the city, this biotech park would be
the first such endeavour in the North East(NE).
BioRad
Laboratories, ICT host chromatography workshop
Bio-Rad Laboratories in association with the Institute of
Chemical Technology ( ICT), Mumbai launched a two day seminar
on Preparative and Process Chromatographic Purification.
Biocon
ties up with Safety Syringes
Biocon has launched a safety device in the form of pre-filled
syringes for two of its life saving products, GCSF (granulocyte-colony
stimulating factor) and EPO (Erythropoietin), in collaboration
with Safety Syringes for the first time in India.
Management
Gujarat's
biotech blueprint
Missing the IT train and leading in pharmaceuticals, Gujarat
is positioning itself as the next destination for biotechnology.
Will it wipe out the already established biotech hubs of the
country or follow a different path? Arshiya Khan maps the
moves
Gujarat
is a politically stable and industry friendly state
Besides active support from Gujarat government and availability
of scientific knowledge, world class infrastructure is another
crucial factor that has promoted the success story of the
Biotechnology Park at Savli, Gujarat. Ajay Pawar, Project
Director of Akruti TCG Biotech, the company behind the construction
of this biotech park provides more details to Sachin Jagdale
Microsoft
Dynamics AX 3.0 at LifeCell
IT always has had vital applications across sectors. Healthcare
and pharma have in a big way benefited by the same. At a time
when stem cells are hopefully proving to be an answer to the
incurable diseases, LifeCell, is a major cord blood stem cell
bank, has improved its business statistics and business control
by implementing IT solutions
Registering
biosimilars in the EU
A review of the biosimilars registration process in the European
Union
We
work very closely with our customers
Shimadzu is an innovative technology provider. Sachin Jagdale
puts across key queries to Senya Imamichi, deputy managing
director, Shimadzu Analytical India to know more
Eco
friendly concept is not new to India
Advanced Enzyme Technologies is one of the important players
in Indian and global market that provide eco friendly enzymes.
C L Rathi, managing director of Advanced Enzyme Technologies
analyses more in talks with Sachin Jagdale \
Pipette
calibration - Trust your assay results
A pipette is a laboratory instrument used to transport a measured
volume of liquid. It works by creating a vacuum above the
liquid-holding chamber and selectively releasing this vacuum
to draw up and dispense liquid.
Products
Technology
Diagnostics
Special
The diagnostics segment in India, considered a part of the
services segment of the biotechnology industry, is already
at forefront of the silent revolution in healthcare delivery
models. We see companies setting up chains of diagnostics
laboratories, some of them reaching out to the rural hinterland
of the country. Within these laboratories and in hospitals
across the country, we have a relatively new set of diagnostic
tools, which work at the molecular level, to 'see' into our
genes and predict possibility of disease and once diagnosed,
another set of tests to help doctors customise treatment depending
on disease load.
In our first Diagnostics Special, we profile two companies,
who probably typify hundreds of Indian diagnostics-based entities
at various stages of the business development cycle. While
Yashraj Biotechnology came up with an innovative project to
purify proteins, the antigens in such kits, from human biomedical
waste, Acton Biotech's diagnostics tests help a doctor measure
disease load in cancer patients and thus decide treatment
regimen. Sachin Jagdale analyses the growth paths of these
two companies.
Diagnosing
growth
The Indian pathology industry is all geared up to become the
most successful growth story in the Indian healthcare industry.
Sonal Shukla explores its future potential
Flow
Cytometry as a diagnostic tool
Flow Cytometry has become an integral research tool to categorise
cells. A review of its applications
|
